Literature DB >> 16642437

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Xian-Zhang Hu1, Robert H Lipsky1, Guanshan Zhu1, Longina A Akhtar1, Julie Taubman1, Benjamin D Greenberg2, Ke Xu1, Paul D Arnold3, Margaret A Richter3, James L Kennedy3, Dennis L Murphy4, David Goldman5.   

Abstract

A functional serotonin transporter promoter polymorphism, HTTLPR, alters the risk of disease as well as brain morphometry and function. Here, we show that HTTLPR is functionally triallelic. The L(G) allele, which is the L allele with a common G substitution, creates a functional AP2 transcription-factor binding site. Expression assays in 62 lymphoblastoid cell lines representing the six genotypes and in transfected raphe-derived cells showed codominant allele action and low, nearly equivalent expression for the S and L(G) alleles, accounting for more variation in HTT expression than previously recognized. The gain-of-function L(A)L(A) genotype was approximately twice as common in 169 whites with obsessive-compulsive disorder (OCD) than in 253 ethnically matched controls. We performed a replication study in 175 trios consisting of probands with OCD and their parents. The L(A) allele was twofold overtransmitted to the patients with OCD. The HTTLPR L(A)L(A) genotype exerts a moderate (1.8-fold) effect on risk of OCD, which crystallizes the evidence that the HTT gene has a role in OCD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642437      PMCID: PMC1474042          DOI: 10.1086/503850

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells.

Authors:  C E Fiskerstrand; E A Lovejoy; J P Quinn
Journal:  FEBS Lett       Date:  1999-09-17       Impact factor: 4.124

2.  Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells.

Authors:  O V Mortensen; M Thomassen; M B Larsen; S R Whittemore; O Wiborg
Journal:  Brain Res Mol Brain Res       Date:  1999-05-07

3.  The TDT is a statistically valid test: comments on Wittkowski and Liu.

Authors:  Warren J Ewens; Richard S Spielman
Journal:  Hum Hered       Date:  2004       Impact factor: 0.444

4.  Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.

Authors:  K Y Little; D P McLaughlin; L Zhang; C S Livermore; G W Dalack; P R McFinton; Z S DelProposto; E Hill; B J Cassin; S J Watson; E H Cook
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

5.  A novel allelic variant of the human serotonin transporter gene regulatory polymorphism.

Authors:  S J Delbrück; B Wendel; I Grunewald; T Sander; D Morris-Rosendahl; M A Crocq; W H Berrettini; M R Hoehe
Journal:  Cytogenet Cell Genet       Date:  1997

6.  Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide.

Authors:  K Y Little; D P McLauglin; J Ranc; J Gilmore; J F Lopez; S J Watson; F I Carroll; J D Butts
Journal:  Biol Psychiatry       Date:  1997-06-15       Impact factor: 13.382

7.  Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders.

Authors:  A Seretti; C Cusin; E Lattuada; D Di Bella; M Catalano; E Smeraldi
Journal:  Mol Psychiatry       Date:  1999-05       Impact factor: 15.992

8.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

9.  Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates.

Authors:  Christina S Barr; Timothy K Newman; Stephen Lindell; Courtney Shannon; Maribeth Champoux; Klaus Peter Lesch; Stephen J Suomi; David Goldman; J Dee Higley
Journal:  Arch Gen Psychiatry       Date:  2004-11

10.  Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.

Authors:  Paul D Carey; James Warwick; Dana J H Niehaus; Geoffrey van der Linden; Barend B van Heerden; Brian H Harvey; Soraya Seedat; Dan J Stein
Journal:  BMC Psychiatry       Date:  2004-10-14       Impact factor: 3.630

View more
  420 in total

1.  Genetic moderation of sensitivity to positive and negative affect in marriage.

Authors:  Dominik Schoebi; Baldwin M Way; Benjamin R Karney; Thomas N Bradbury
Journal:  Emotion       Date:  2011-12-12

2.  Rationality and emotionality: serotonin transporter genotype influences reasoning bias.

Authors:  Melanie Stollstorff; Stephanie E Bean; Lindsay M Anderson; Joseph M Devaney; Chandan J Vaidya
Journal:  Soc Cogn Affect Neurosci       Date:  2012-01-24       Impact factor: 3.436

3.  Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+.

Authors:  Murat Oz; Therissa Libby; Bronwyn Kivell; Vanaja Jaligam; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

4.  Central serotonin transporter levels are associated with stress hormone response and anxiety.

Authors:  Matthias Reimold; Astrid Knobel; Michael A Rapp; Anil Batra; Klaus Wiedemann; Andreas Ströhle; Anke Zimmer; Peter Schönknecht; Michael N Smolka; Daniel R Weinberger; David Goldman; Hans-Jürgen Machulla; Roland Bares; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2010-06-29       Impact factor: 4.530

Review 5.  Genetics of emotion.

Authors:  Laura Bevilacqua; David Goldman
Journal:  Trends Cogn Sci       Date:  2011-08-10       Impact factor: 20.229

6.  Sleep quality varies as a function of 5-HTTLPR genotype and stress.

Authors:  Beverly H Brummett; Andrew D Krystal; Allison Ashley-Koch; Cynthia M Kuhn; Stephan Züchner; Ilene C Siegler; John C Barefoot; Edna L Ballard; Lisa P Gwyther; Redford B Williams
Journal:  Psychosom Med       Date:  2007-08-31       Impact factor: 4.312

7.  Sex-specific pathways among tri-allelic serotonin transporter polymorphism, trait neuroticism and generalized anxiety disorder.

Authors:  Hsin-An Chang; Wen-Hui Fang; Yia-Ping Liu; Nian-Sheng Tzeng; Jia-Fwu Shyu; Fang-Jung Wan; San-Yuan Huang; Tieh-Ching Chang; Chuan-Chia Chang
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

Review 8.  A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Authors:  Meredith A Fox; Anne M Andrews; Jens R Wendland; Klaus-Peter Lesch; Andrew Holmes; Dennis L Murphy
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

9.  Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.

Authors:  M Reimold; M N Smolka; A Zimmer; A Batra; A Knobel; C Solbach; A Mundt; H U Smoltczyk; D Goldman; K Mann; G Reischl; H-J Machulla; R Bares; A Heinz
Journal:  J Neural Transm (Vienna)       Date:  2007-08-22       Impact factor: 3.575

10.  A Hierarchical Factor Model of Executive Functions in Adolescents: Evidence of Gene-Environment Interplay.

Authors:  James J Li; Tammy A Chung; Michael M Vanyukov; D Scott Wood; Robert Ferrell; Duncan B Clark
Journal:  J Int Neuropsychol Soc       Date:  2014-12-15       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.